CV safety with weight loss agent in high-risk overweight or obese patients
This 3-minute education provides a summary of just presented scientific data, recorded during the ESC 2018 congress. The objective is to provide a brief commentary and potential implications of these findings.
Dr Erin Bohula is Associate Prof at Brigham and Women's Hospital, Boston, MA, USA.
The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of ipccs.org. Ipccs.org did not receive financial support for the production of this 3-minute education.
Read our summary of the CAMELLIA-TIMI 61 trial
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: